In this July 4, 2021 file photo, Pope Francis waves to the crowd as he arrives to recite the Angelus noon prayer from the window of his studio overlooking St. Peter's Square, at the Vatican.... The Vatican has given scant details about the operation Sunday evening in Gemelli Polyclinic, a major Catholic hospital in the Italian capital.... An Italian cardinal told reporters he had been informed that the pope was doing well....

A pulse oximeter lent to coronavirus patients convalescing at home is seen in Kitakyushu, Fukuoka

confused in public, or takes some time to convalesce, there are questions about their fitness for office....

normal convalescence. The Vatican said the pope will go ahead with his Sunday noon prayer but that a

virus.... The part of the blood that contains antibodies, so-called convalescent plasma, has been

set up a joint venture company called ReU Living Sdn Bhd, which will focus on operating convalescent

ZURICH( Reuters)-Swiss National Bank Chairman Thomas Jordan is in good condition after a successful medical operation over the weekend, the central bank said on Monday.... Jordan had to undergo a medical procedure at the weekend, which proved necessary after a check-up, it said.... " The operation was successful and Thomas Jordan is in a good condition," the SNB said in a statement....

Researchers in Singapore have developed a smart bandage to enable patients to have chronic wounds monitored remotely via an app on a mobile device, potentially saving them visits to the doctor.A research team at the National University of Singapore has created a wearable sensor attached to a transparent bandage to track progress in healing, using information like temperature, bacteria type, and levels of pH and inflammation." Traditionally when someone has a wound or ulcer, if it's infected, the

In the study, the blood of people who were infected in the first wave of the pandemic and then recovered seemed to have retained antibodies for up to at least 10 months post-onset of symptoms( POS).... The research team’s latest study followed an earlier study, also concerned with how long the antibodies stayed in the blood of Covid-19 patients.... The research team wrote in the study paper, led by Liane Dupont, an Infectious disease from King's College London:" Initial concerns were that the

The British drugmaker has announced its COVID-19 antibody drug was 83 percent effective in cutting the risk of people contracting symptomatic illness in a six-month follow-up study.... It cements AstraZeneca's lead in developing a preventive treatment for coronavirus.... The company also found that patients with mild-to-moderate COVID-19 showed that a higher dose of the therapy, AZD7442, cut the risk of symptoms worsening by 88 percent when given within three days of first symptoms.It means As